Increased endothelial apoptotic cell density in human diabetic erectile tissue - Comparison with clinical data

Journal of Sexual Medicine

Volumn 6, Issue 3, 2009, Pages 826-835

  Costa, Carla ^a,b   Soares, Raquel ^a   Castela, Ângela ^a   Adães, Sara ^a,c   Hastert, Véronique ^d   Vendeira, Pedro ^b,e   Virag, Ronald ^d  

^a University of Porto   (Portugal)

^b iSEX Association for the Advanced Study of Human Sexuality   (Portugal)

^c UNIVERSITY OF PORTO   (Portugal)

^d Centre d'Explorations et Traitements de l'Impuissance (CETI)   (France)

^e HOSPITAL DE SÃO JOÃO   (Portugal)

Author keywords

Apoptotic Cell Density; Cavernous Tissue; Diabetes; Erectile Dysfunction

Indexed keywords

NITRIC OXIDE; VASOACTIVE AGENT;

ADULT; APOPTOSIS; ARTERY OCCLUSION; ARTICLE; CELL DENSITY; CELL PROLIFERATION; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORPUS CAVERNOSUM; DIABETES MELLITUS; ENDOTHELIAL DYSFUNCTION; ERECTILE DYSFUNCTION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; NICK END LABELING; PENIS ERECTION; PENIS PROSTHESIS; PRIORITY JOURNAL; RISK FACTOR; VEIN OCCLUSION;

EID: 61549106634     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2008.01110.x     Document Type: Article

References (33)

1. Meetoo D, McGovern P, Safadi R. An epidemiological overview of diabetes across the world. Br J Nurs 2007;16:1002-7.
2. Saenz T. Pathophysiology of erectile dysfunction. J Sex Med 2005;2:26-39.
3. DeRogatis LR, Burnett AL. The epidemiology of sexual dysfunctions. J Sex Med 2008;5:289-300.
4. Prieto D. Physiological regulation of penile arteries and veins. Int J Impot Res 2008;20:17-29.
5. Nessar A. Advanced glycation end products-Role in pathology of diabetic complications. Diabetes Res Clin Pract 2005;67:3-21.
6. Angulo J, Cuevas P, Fernández A, Gabancho S, Allona A, Martín-Morales A, Moncada I, Videla S, Sáenz de Tejada I. Diabetes impairs endothelium-dependent relaxation of human penile vascular tissues mediated by NO and EDHF. Biochem Biophys Res Commun 2003;312:1202-8.
7. Musicki B, Burnett AL. eNOS function and dysfunction in the penis. Exp Biol Med (Maywood) 2006;231:154-65.
8. Zúrová-Nedelcevová J, Navarová J, Drábiková K, Jancinová V, Petríková M, Bernátová I, Kristová V, Snirc V, Nosál'ová V, Sotníková R. Participation of reactive oxygen species in diabetes-induced endothelial dysfunction. Neuro Endocrinol Lett 2006;27:168-71.
9. Rojas A, Morales MA. Advanced glycation and endothelial functions: A link towards vascular complications in diabetes. Life Sci 2004;76:715-30.
10. Musicki B, Burnett AL. Endothelial dysfunction in diabetic erectile dysfunction. Int J Impot Res 2007;19:129-38.
11. Seftel AD, Maclennan GT, Chen ZJ, Liu S, Ferguson K, Deoreo G, Levine F, Hampel N, Ho-Chang C. Loss of TGFbeta, apoptosis, and Bcl-2 in erectile dysfunction and upregulation of p53 and HIF-1alpha in diabetes-associated erectile dysfunction. Mol Urol 1999;3:103-7.
12. Alici B, Gümüstas MK, Ozkara H, Akkus E, Demirel G, Yencilek F, Hattat H. Apoptosis in the erectile tissues of diabetic and healthy rats. BJU Int 2000;85:326-9.
13. Wang D, Xie H, Wang G. Apoptosis and the expression of Bax and Bcl-2 in the penis of diabetic rats. Zhonghua Nan Ke Xue 2004;10:844-8.
14. Liu J, Xia R, Fu W, Chen Y, Liu G. Apoptosis and hemodynamic changes of the penile tissue in diabetic rats. Zhonghua Nan Ke Xue 2004;10:445-8.
15. Park K, Ryu KS, Li WJ, Kim SW, Paick JS. Chronic treatment with a type 5 phosphodiesterase inhibitor suppresses apoptosis of corporal smooth muscle by potentiating Akt signalling in a rat model of diabetic erectile dysfunction. Eur Urol 2008;53:1282-8.
16. Esposito K, Ciotola M, Giugliano F, Sardelli L, Giugliano F, Maiorino MI, Beneduce F, De Sio M, Giugliano D. Phenotypic assessment of endothelial microparticles in diabetic and nondiabetic men with erectile dysfunction. J Sex Med 2008;5:1436-42.
17. Virag R. Flow-dependent dilatation of the cavernous artery. A potential test of penile NO content. J Mal Vasc 2002;27:214-7.
18. Virag R, Floresco J, Richard C. Impairment of shear-stress-mediated vasodilation of cavernous arteries in erectile dysfunction. Int J Impot Res 2004;16:39-42.
19. Costa C, Vendeira P. Does erectile tissue angioarchitecture modify with aging? An immunohistological and morphometric approach. J Sex Med 2008;5:833-40.
20. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992;119:493-501.
21. Dey J, Shepherd MD. Evaluation and treatment of erectile dysfunction in men with diabetes mellitus. Mayo Clin Proc 2002;77:276-82.
22. De Vriese AS, Verbeuren TJ, Van de Voorde J, Lameire NH, Vanhoutte PM. Endothelial dysfunction in diabetes. Br J Pharmacol 2000;130:963-74.
23. LeRoith D. Treatment of diabetes: A clinical update on insulin trials. Clin Cornerstone 2007;8:21-9.
24. Brownlee M. Glycation products and the pathogenesis of diabetic complications. Diabetes Care 1992;15:1835-43.
25. Virag R, Bouilly P, Frydman D. Is impotence an arterial disorder? A study of arterial risk factors in 440 impotent men. Lancet 1985;1:181-4.
26. Meyer MF, Lieps D, Schatz H, Klein HH, Pfohl M. Influence of the duration of type 2 diabetes on early functional and morphological markers of atherosclerosis compared to the impact of coexisting classic cardiovascular risk factors. Exp Clin Endocrinol Diabetes 2008;116:298-304.
27. Tsuchiya K, Nakayama C, Iwashima F, Sakai H, Izumiyama H, Doi M, Hirata Y. Advanced endothelial dysfunction in diabetic patients with multiple risk factors; Importance of insulin resistance. J Atheroscler Thromb 2007;14:303-9.
28. Martin A, Komada MR, Sane DC. Abnormal angiogenesis in diabetes mellitus. Med Res Rev 2003;2:117-45.
29. Costa C, Incio J, Soares R. Angiogenesis and chronic inflammation: Cause or consequence? Angiogenesis 2007;10:149-66.
30. Vickers MA, Satyanarayana R. Phosphodiesterase type 5 inhibitors for the treatment of erectile dysfunction in patients with diabetes mellitus. Int J Impot Res 2002;14:466-71.
31. Virag R, Shoukry K, Floresco J, Nollet F, Greco E. Intracavernous self-injection of vasoactive drugs in the treatment of impotence: 8-year experience with 615 cases. J Urol 1991;145:287-92.
32. Virag R. Intracavernous injection of papaverine for erectile failure. Lancet 1982;2:938.
33. Lin CS, Lin G, Lue TF. Cyclic nucleotide signaling in cavernous smooth muscle. J Sex Med 2005;2:478-91.